MedCodeSearch
HCPCS Level II Current in October 2026

Q5107

Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg

Release
October 2026
Effective
Official source (opens in a new tab)

Official Coding Notes

Reproduced verbatim from the October 2026 HCPCS Level II files.

Note

PUB. 100-4, CHAPTER 17.

Version History

How Q5107 appears in each release imported from the official files, newest first.

  1. October 2026 Effective

    Current

    Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg

  2. July 2026 Effective

    Unchanged

    Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg

  3. April 2026 Effective

    Unchanged

    Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg

  4. January 2026 Effective

    Unchanged

    Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg

Data Source

Code information on this page is derived from the October 2026 HCPCS Level II files published by CMS.

Release
October 2026
Effective
Source file
october-2026-alpha-numeric-hcpcs-file.zip

Official HCPCS Level II source files (opens in a new tab)

MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.

Look up another code

Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.